Close
Smartlab Europe
Inizio Ignite

Upsher-Smith launches new prenatal vitamin

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Therapeutic Frontiers in Malignant Mesothelioma Management

Malignant mesothelioma is one of oncology’s most challenging diagnoses....

CRO Clinical Trials: Structure and Purpose in Modern Research

Clinical trials require carefully organized processes to ensure that...

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...
- Advertisement -

Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP).

B-Nexa is designed with B vitamins and ginger to help calm NVP, also known as morning sickness, the most common symptom of pregnancy, the company said. Taken once or twice daily, B-Nexa contains vitamin B6 and ginger to help calm nausea and vomiting during pregnancy. Each antihistamine-free tablet also contains 1.2mg folic acid.

Upsher-Smith medical affairs senior director Wesley Todd said that B-Nexa is a new option in the prenatal nutrition market that has been designed to help calm nausea and vomiting of pregnancy.

Latest stories

Related stories

Therapeutic Frontiers in Malignant Mesothelioma Management

Malignant mesothelioma is one of oncology’s most challenging diagnoses....

CRO Clinical Trials: Structure and Purpose in Modern Research

Clinical trials require carefully organized processes to ensure that...

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...

Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience

Novartis has entered into a licensing agreement with SciNeuro...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »